Skip to main content

Table 2 Outcome measures assessed pre- and post-participation in the walking intervention (n = 17)

From: Safety, feasibility and effects of an individualised walking intervention for women undergoing chemotherapy for ovarian cancer: a pilot study

Outcome

Baseline

Follow-up

 
 

Median

(min, max)

Median

(min, max)

P-valuea

Physical functioningb

332 (266, 356)

395 (356, 460)*

0.01

Anxiety

4 (1, 15)

4 (0, 16)

0.63

Depression

3 (0, 16)

4 (0, 13)

0.16

Physical symptoms

1.06 (0.0, 2.33)

0.60 (0.06, 2.06)*

0.14

Quality of lifec (FACT-O)

109 (72, 146)

113 (67, 148)

0.10

   Physical wellbeing

18 (12, 27)

23 (12.0, 28)*

0.08

   Social wellbeing

23 (12, 28)

22 (8, 28)

0.11

   Emotional wellbeing

20 (7, 24)

21 (10, 24)

0.29

   Functional wellbeing

19 (7, 28)

19 (7, 28)

0.02

   Ovarian-specific concerns

31 (20, 41)

36 (21, 44)*

0.04

  1. Clinically meaningful change;*
  2. Wilcoxon signed ranked test used for analysis;a
  3. Physical functioning is measured in metres (m)
  4. Physical functioning data not collected for seven regional women due to inaccessibility;b
  5. A higher score indicates a better quality of life;c
  6. Functional Assessment of Cancer Therapy-Ovary; FACT-O
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us